Yarrow Bioscience (YARW) Net Income by Year
Yarrow Bioscience, Inc. reported a net loss of $26.5M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Yarrow Bioscience, Inc. has filed alongside them.
Ticker history: VYNE became YARW (Yarrow Bioscience, Inc.) on . Earlier news and filings retain their original names and dates. View VYNE history.
Annual figures, oldest first. Point at a bar to read its period.
YARW Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
YARW Net Income by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Yarrow Bioscience, Inc. financials
Frequently Asked Questions
Yarrow Bioscience, Inc. reported a net loss of $26.5M in fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported a $39.8M net loss in fiscal year 2024 and a $26.5M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 11 fiscal years this page covers, Yarrow Bioscience, Inc. (YARW) net income went from -$4.6M in fiscal year 2015 to -$26.5M in fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported -$3.0M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Yarrow Bioscience, Inc. (YARW) reported on that line in every period on record.